Improvements on a chemically contiguous hapten for a vaccine to address fentanyl-contaminated heroin.
Improvements on a chemically contiguous hapten for a vaccine to address fentanyl-contaminated heroin.
复制标题
DOI:
10.1016/j.bmc.2021.116225
复制
发表时间:
2021-05
影响因子:
3.5
通讯作者:
Hyeri Park;J. Lee;L. M. Eubanks;Beverly Ellis;Bin Zhou;K. Janda
中科院分区:
文献类型:
--
作者:
Hyeri Park;J. Lee;L. M. Eubanks;Beverly Ellis;Bin Zhou;K. Janda
Unintentional overdose deaths related to opioids and psychostimulants have increased in prevalence due to the adulteration of these drugs with fentanyl. Synergistic effects between illicit compounds and fentanyl cause aggravated respiratory depression, leading to inadvertent fatalities. Traditional small-molecule therapies implemented in the expanding opioid epidemic present numerous problems since they interact with the same opioid receptors in the brain as the abused drugs. In this study, we report an optimized dual hapten for use as an immunopharmacotherapeutic tool in order to develop antibodies capable of binding to fentanyl-contaminated heroin in the periphery, thus impeding the drugs’ psychoactive effects on the central nervous system. This vaccine produced antibodies with nanomolar affinities and effectively blocked opioid analgesic effects elicited by adulterated heroin. These findings provide further insight into the development of chemically contiguous haptens for broad-spectrum immunopharmacotherapies against opioid use disorders.